An Open-Label Study of Tolvaptan in the Heart Failure Patients With Volume Overload

被引：1
|
作者：
Fukunami, Masatake [1 ]
Matsuzaki, Masunori [2 ]
Hori, Masatsugu [3 ]
Izumi, Tohru [4 ]
机构：
[1] Ctr Cardiovasc, Osaka, Japan
[2] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi 755, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[4] Kitasato Univ, Sch Med, Dept Cardioangiol, Sagamihara, Kanagawa 228, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2010年 / 16卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2010.07.148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [41] Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study
    Bonnekoh, Hanna
    Frischbutter, Stefan
    Roll, Stephanie
    Maurer, Marcus
    Krause, Karoline
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06): : 2486 - +
  • [42] Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload
    Sato, Yuichi
    Dohi, Kaoru
    Watanabe, Kiyotaka
    Tanimura, Muneyoshi
    Takeuchi, Tetsushiro
    Sugiura, Emiyo
    Suoimoto, Tadafumi
    Kumagai, Naoto
    Ogura, Toru
    Nakamori, Shiro
    Fujimoto, Naoki
    Yamada, Norikazu
    Ito, Masaaki
    INTERNATIONAL HEART JOURNAL, 2016, 57 (02) : 211 - 219
  • [43] Mycophenolate mofetil: an open-label study in 42 MS patients
    Ducray, F
    Vukusic, S
    Gignoux, L
    Durand-Dubief, F
    Renoux, C
    Achiti, I
    Blanc, S
    Confavreux, C
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S263 - S263
  • [44] An open-label study of quetiapine for delirium
    Maneeton, N.
    Maneeton, B.
    Srisurapanont, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S487 - S488
  • [45] Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure
    Fujisue, Koichiro
    Ito, Miwa
    Matsuzawa, Yasushi
    Arima, Yuichiro
    Takashio, Seiji
    Sueta, Daisuke
    Araki, Satoshi
    Hanatani, Shinsuke
    Yamanaga, Kenshi
    Yamamoto, Masahiro
    Kaneko, Shozo
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Soejima, Hirofumi
    Tsujita, Kenichi
    CIRCULATION REPORTS, 2024, 6 (03) : 55 - 63
  • [46] Long-term, open-label experience with an endothelin receptor antagonist, bosentan, in patients with severe chronic heart failure
    Krum, H
    Charlon, V
    Widmann, T
    Packer, M
    CIRCULATION, 1999, 100 (18) : 646 - 647
  • [47] Volume overload and co-morbid conditions of hospitalized heart failure patients
    Aaronson, K
    Russman, P
    Bruckman, D
    Koelling, T
    Dyke, DB
    Cody, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 236A - 236A
  • [48] A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis
    Kiwamu Okita
    Isao Sakaida
    Mitsuru Okada
    Akira Kaneko
    Kazuaki Chayama
    Michio Kato
    Michio Sata
    Naomasa Yoshihara
    Noriyuki Ono
    Yoshikazu Murawaki
    Journal of Gastroenterology, 2010, 45 : 979 - 987
  • [49] Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
    Suzuki, Shunji
    Hanafusa, Norio
    Kubota, Kenji
    Tsuchiya, Ken
    Nitta, Kosaku
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2018, 11 : 235 - 240
  • [50] The efficacy of tolvaptan in congestive heart failure patients with and without hypoalbuminemia: a pilot study
    Okabe, T. Toshitaka
    Yakushiji, T.
    Ebara, S.
    Yamashita, K.
    Yamamoto, M. H.
    Hoshimoto, K.
    Amemiya, K.
    Isomura, N.
    Araki, H.
    Ochiai, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 336 - 337
12345